425 related articles for article (PubMed ID: 31114136)
21. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
[TBL] [Abstract][Full Text] [Related]
22. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
[TBL] [Abstract][Full Text] [Related]
23. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.
Lee HS; Hwang SM; Kim TS; Kim DW; Park DJ; Kang SB; Kim HH; Park KU
Transl Oncol; 2013 Jun; 6(3):290-6. PubMed ID: 23730408
[TBL] [Abstract][Full Text] [Related]
24. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
27. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
28. Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer.
Huang Y; Su T; Duan Q; Wei X; Fan X; Wan J; Liu L; Dian Z; Zhang G; Sun Y; Zhou T; Xu Y
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38252186
[TBL] [Abstract][Full Text] [Related]
29. [The new blood test bio-marker SEPT9 and colorectal carcinoma screening].
Beneš Z; Sedivcová M; Antoš Z; Kohout P; Puškárová G; Cerník M; Rozmahel M; Shánělová M; Dolina J; Hep A; Trubač M; Stehlík J; Vaněček T; Michal M; Simša J; Kala Z
Vnitr Lek; 2013 Nov; 59(11):971-6. PubMed ID: 24279440
[TBL] [Abstract][Full Text] [Related]
30. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
31. Methylated Septin9 (m
Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].
He N; Feng G; Zhang FN; Hao S; Li R; Zhao ZQ; Tian YW; Yan HL
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):265-270. PubMed ID: 37137852
[No Abstract] [Full Text] [Related]
33. Septin 9 methylation analysis of lymph node micrometastases for predicting relapse of colorectal cancer.
Wan Y; Liang JJ; Luo XJ; Zhu XJ; He JL; Wang SB; Zhao YY; Zeng D; Zhang L; Tang XK
Ann Diagn Pathol; 2022 Oct; 60():152021. PubMed ID: 35939880
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
Wang DS; Zhong B; Zhang MS; Gao Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
[TBL] [Abstract][Full Text] [Related]
35. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
36. Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
Yuan Z; Wang S; Ni K; Zhan Y; Ma H; Liu X; Xin R; Zhou X; Liu Z; Zhao X; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Cui W; Zhang X; Zhang Q; Zhang C
Med Sci Monit; 2022 Sep; 28():e937757. PubMed ID: 36117308
[TBL] [Abstract][Full Text] [Related]
37. The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA.
He N; Song L; Kang Q; Jin P; Cai G; Zhou J; Zhou G; Sheng J; Cai S; Wang J; Han X; Nie Y; Wu K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818791794. PubMed ID: 30223720
[TBL] [Abstract][Full Text] [Related]
38. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
[TBL] [Abstract][Full Text] [Related]
39. SEPT9: A Specific Circulating Biomarker for Colorectal Cancer.
Song L; Li Y
Adv Clin Chem; 2015; 72():171-204. PubMed ID: 26471083
[TBL] [Abstract][Full Text] [Related]
40. External quality assessment for detection of colorectal cancer by Septin9 DNA methylation in clinical laboratories.
Chang L; Wang D; Han Y; Diao Z; Chen Y; Li J; Zhang R
Clin Chim Acta; 2024 Jan; 552():117663. PubMed ID: 38008152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
